The prognosis of biopsy-proven lupus nephritis in Chinese patients: Long-term follow-up of 86 cases

Chinese Medical Journal

Volumn 110, Issue 7, 1997, Pages 502-507

  Shen, Keqin ^a   Yu, Yusheng ^a   Tang, Zheng ^a   Liu, Zhihong ^a   Li, Leishi ^a  

^a JINLING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; FEMALE; FOLLOW UP; HUMAN; KIDNEY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEEDLE BIOPSY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TRIPTERYGIUM;

ADULT; BIOPSY, NEEDLE; CYCLOPHOSPHAMIDE; DRUGS, CHINESE HERBAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; TRIPTERYGIUM;

EID: 2442625601     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Urowitz MB. Lupus activity criteria count. Arthritis Rheum 1982; 25:S78.
2. Appel GB, Cohen DJ, Pirani CL, et al. Long-term follow-up of patients with lupus nephritis. Am J Med 1987; 83:877.
3. Bakir AA, Levy PS, Dunea G. The prognosis of lupus nephritis in African-Americans; a retrospective analysis. Am J Kidney Dis 1994; 24(2):159.
4. Austin HA, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. Controlled trial of prednisone and eytotoxic drugs. N Engl J Med 1986; 314:614.
5. Walker RJ, Bailey RR, Swainson CP, et al. Lupus nephritis: a 13-year experience. N Z Med J 1986; 99:894.
6. Schwartz MM, Kawala KS, Cjorwin HL, et al. The prognosis of segmental glomerulonephritis in systemic lupus erythematosus. Kidney Int 1987; 32:274.
7. Leaker BJ, Fairley KF, Dowling J, et al. Lupus nephritis: clinical and pathological correlation. Q J Med 1987; 62:163.
8. Esdaile JM, Levinton C, Federgreen W, et al. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 1989; 72:779.
9. Lewis J, Hunsicker LG , Lan SP, et al. A controlled trial of plasma-phresis therapy in severe lupus nephritis. N Engl J Med 1992; 326:1373.
10. Boumpas DT, Austin HA, Vaugha EM, et al. Controlled trial of pulse methylprednisone fersus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992; 340:741.
11. Delahousse M, Attroun L, Kenoch S, et al. Intravenous pulse cyclophosphamide therapy for lupus nephritis. J Am Soc Nephrol 1993; 4:273.
12. Austin III HA, Boumpas DT, Vaughan EM, et al. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 1994; 45:544.
13. Austin III HA, Muenz LR, Joyce KM, et al. Diffuse proliferative upus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25:689.